Danaher Corporation (LON:0R2B)
207.43
-2.36 (-1.13%)
Mar 28, 2025, 7:21 PM BST
Danaher Revenue
In the year 2024, Danaher had annual revenue of $23.88B USD, down -0.06%. Danaher had revenue of $6.54B in the quarter ending December 31, 2024, with 2.08% growth.
Revenue
$23.88B
Revenue Growth
-0.06%
P/S Ratio
n/a
Revenue / Employee
$378.97K
Employees
63,000
Market Cap
113.65B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Danaher News
- 6 days ago - Looking Into Danaher's Recent Short Interest - Benzinga
- 6 days ago - 8 Upcoming Dividend Increases, Including A King - Seeking Alpha
- 9 days ago - Danaher: Near 5-Year Low Is A Great Entry Point - Seeking Alpha
- 10 days ago - Check Out What Whales Are Doing With DHR - Benzinga
- 10 days ago - Goldman upgrades this conglomerate, sees 20% upside - CNBC
- 10 days ago - Danaher Schedules First Quarter 2025 Earnings Conference Call - PRNewsWire
- 16 days ago - Danaher Stock Has Fallen Far Enough. Buy It Now, Says Analyst. - Barron's
- 17 days ago - Unpacking the Latest Options Trading Trends in Danaher - Benzinga